Oscar Health (OSCR) Cash from Investing Activities (2020 - 2026)

Oscar Health (OSCR) has 7 years of Cash from Investing Activities data on file, last reported at -$590.3 million in Q1 2026.

• Quarterly Cash from Investing Activities fell 238.78% year-over-year to -$590.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$657.1 million (up 47.89% YoY) and the FY2025 annual result came in at -$241.1 million, up 82.63% from the prior year.
• Cash from Investing Activities slipped to -$590.3 million in Q1 2026, from -$48.7 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $298.8 million in Q3 2022 to a low of -$706.7 million in Q4 2022.
• A 5-year average of -$109.9 million and a median of -$31.4 million in 2024 frame the typical range for Cash from Investing Activities.
• The widest YoY moves for Cash from Investing Activities: up 2516.48% in 2022, down 3462.43% in 2022.
• Tracing OSCR's Cash from Investing Activities over 5 years: stood at -$706.7 million in 2022, then surged by 124.41% to $172.5 million in 2023, then plunged by 118.23% to -$31.4 million in 2024, then slumped by 54.88% to -$48.7 million in 2025, then tumbled by 1111.87% to -$590.3 million in 2026.
• The last three Cash from Investing Activities figures came in at -$590.3 million (Q1 2026), -$48.7 million (Q4 2025), and $150.1 million (Q3 2025), per Business Quant data.